NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Septemb...
September 05 2017 - 1:00PM
Business Wire
NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be
a presenting company at the 19th Annual Rodman &
Renshaw Global Investment Conference, sponsored by H.C.
Wainwright & Co., LLC. The conference is being
held on September 10-12, 2017, at Lotte New York
Palace Hotel in New York City. Shai N. Gozani, M.D., Ph.D.,
President and CEO of NeuroMetrix, will provide an overview of
the Company's business during the live presentation and will be
available to participate in one-on-one meetings with investors who
are registered to attend the conference.
The NeuroMetrix presentation is scheduled for Monday,
September 11, 2017 at 11:15 AM Eastern time. A live audio
webcast will be available on the investor relations section of the
corporate website, www.NeuroMetrix.com. This webcast will be
archived after the live event.
About NeuroMetrix
NeuroMetrix is a commercial stage, innovation driven
healthcare company combining neurostimulation and digital medicine
to address chronic health conditions including chronic pain, sleep
disorders, and diabetes. The company's lead product is Quell®, an
over-the-counter wearable therapeutic device for chronic pain.
Quell is integrated into a digital health platform that helps
patients optimize their therapy and decrease the impact of chronic
pain on their quality of life. The company also markets DPNCheck®,
a rapid point-of-care test for diabetic neuropathy, which is the
most common long-term complication of Type 2 diabetes. The company
maintains an active research effort and has several pipeline
programs. The company is located in Waltham,
Massachusetts and was founded as a spinoff from
the Harvard-MIT Division of Health Sciences and
Technology in 1996. For more information, please
visit NeuroMetrix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170905006012/en/
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial OfficerNeurometrix.ir@neurometrix.com
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024